NEW DELHI and LONDON and MUNICH, Jan. 28, 2025 /PRNewswire/ — Datar Cancer Genetics (DCG) has launched a revolutionary video-reporting service for in-vitro chemosensitivity testing, powered by AI-driven technology. This innovation provides oncologists with real-time visual evidence of…